ABSTRACT
INTRODUCTION
Thyroid disorders are amongst the most common endocrine diseases in India (1) . The prevalence and pattern of thyroid disorders depends on sex, age, ethnic and geographical factors and especially on iodine intake (2) . A high iodine intake is associated with lower prevalence of goiter and higher prevalence of hypothyroidism. Low intake is associated with a higher prevalence of hyperthyroidism (3) . Hypothyroidism is more common in older women and 10 times more common in women than men (4) . The prevalence of hyperthyroidism is also reported as more common in women than men (5) .
The total burden of thyroid disorders in India is 42 million. This projection was based on recent nationwide studies on thyroid disorders among adolescents and young adults in the post salt iodization phase (1) . There is however a paucity of data from the Union Territory (UT) of Puducherry. A pilot study in 1997 (6) reported a goiter prevalence of 2.6 % in school children and assessed the region as iodine sufficient. We still lack information on thyroid dysfunction amongst women in this region. This study was designed to address this question. Subclinical and clinical forms of Hyperthyroidism and Hypothyroidism can contribute to morbidity from Osteoporosis, Hyperlipidemia, Hypercholesterolemia, Hyperhomocysteinemia, Cardiovascular and Neuropsychiatry disease specially in the older population (7, 8) . We undertook this study to provide reference data for TSH, FT 4 and FT 3 in women of this region and evaluate their status of thyroid function.
MATERIALS AND METHODS

women who attended the Well Women Health Profile
Clinic of the Pondicherry Institute of Medical Sciences formed part of the study group. Their age ranged from 20-80 years. In addition to clinical examination, careful history was taken pertaining to thyroid and or any other illness. Height, weight and blood pressure was recorded. Routine blood investigations included Hemogram, ESR, Peripheral Smear, Blood group and Rh type, Stool and Urine examination. The biochemical investigations included Urea, Creatinine, Fasting and Postprandial blood sugar, Cholesterol and Triglycerides. Thyroid function tests were carried out on all women.
Population studied : Total population -comprised all subjects including those with thyroid disease, risk factors and medication. "Disease free" population -subjects with previous history of thyroid disease, goiter and medication were excluded from the total population to get the "Disease Free population. Reference population -subjects with previous history of thyroid disease and / or surgery and / or thyroid medication and those who evidenced overt thyrotoxicosis or overt hypothyroidism on examination and also women with diabetes mellitus and on drugs like lithium were excluded from the total population to get the reference population. This type of grouping was made as per the norms laid out by earlier studies including the NHANES III study. (9, 10) 505 women formed part of the study group. The highest number was in the 40-49 age group (31.4%) and lowest number in the 70-79 age group (3%). Of the total subjects (n=505), 11.9 % (n=60) had previous history of thyroid disease and/or thyroid surgery and/or use of thyroid medication. The remaining 445 participants were defined as the "disease free population". The reference population constituted 360 subjects.
Laboratory Methods :
The thyrotropin, TSH levels of serum samples were analysed using a 3 rd generation Chemiluminescence immunometric assay kits (Diagnostic Product Corporation(DPC), LosAngeles, USA) on the Immulite 1000 Chemiluminescence Analyser. The analytical sensitivity was 0.004 μIU/ml. The FT 4 and FT 3 levels were also analysed by chemiluminescent assay on Immulite 1000 using DPC kits (DPC-USA). The analytic sensitivity of FT 4 was 0.3 ng/dl and FT 3 was 1.0 pg/ml. All sera samples were stored -20°C. The laboratory's reference values were TSH (0.4 -4.0 μIU/ml), FT 4 (0.8 -2.0 ng/dl), FT 3 (1.5 -4.1 pg/ml). 
RESULTS
Of the 505 total subjects in the age range 20 -80 years, 15.8 % had thyroid dysfunction and 84.2% were euthyroid (Table  1) 11.5% were hypothyroid (2% clinical, 9.5% subclinical) ( Table 2 ). 1.8 % had hyperthyroidism (1.2% clinical and 0.6 % subclinical) while 2.6 % had mildly suppressed TSH with normal FT 4 ( Table 2) . The mean TSH level in the subclinical hypothyroid group was 9.55±7.7 μIU/ml and hyper thyroid group 0.06 ± 0.04 μIU/ml. The mean TSH level in the hypothyroid group was 9.54 ± 6.69 μIU/ml. The median was 6.3 μIU/ml. The 2.5 and 97.5 percentile of TSH was 5.20 and 27.05 μIU/ml. The cut off values for subclinical hypothyroidism was TSH > 4.5 μIU/ml and FT 4 ≥ 0.620 mg/dl. The mean TSH level in the sub clinical hyperthyroid group was 0.06 ± 0.04 μIU/ml. The median was 0.07 μIU/ml. The 2.5 and 97.5 percentiles was 0.03 and 0.10. The cut off values for subclinical hyperthyroidism was TSH ≤ 0.1 μIU/ml and FT 4 ≥1.705mg/dl.
Sixty of the 505 women gave a history of thyroid disease and or thyroid medication. Of these 36.7 % gave biochemical evidence of hypothyroidism (3.3% clinical, 33.3 % subclinical) and 10% had hyperthyroidism (8.3 % clinical and 1.7 % subclinical) ( Table 3 ).On separating the 60 subjects (who self reported thyroid dysfunction or those on thyroid medication) from the total population, a group of 445 subjects, represented the "disease free population". Thyroid dysfunction was seen in 11% whereas 88.98 % were euthyroid (Table 1 ). 8.5% were hypothyroid (2% clinical, 9.5% subclinical), 0.7% were hyperthyroid (0.2% clinical, 0.4% subclinical) and 1.8% had mildly suppressed TSH and normal FT 4 ( Table 2 ).
The geometric mean TSH for the total population was 2.65 μIU/ml. It was lower in the disease free population i.e. 2.43 μIU/ml and was significantly lower in the reference population 2.17 μIU/ml (p=0.025) ( Table 4 ). There was no significant difference in the FT 3 and FT 4 values between the different groups ( Table 4) .
The mean TSH concentration increased with age in all groups.
In the reference population the highest TSH concentration was seen in the age group 60-69 years whereas in the total and disease free population in the age group 70 -79 years. (Table  5 ). There was no significant difference in FT 4 with age in the different populations. However the FT 3 values declined with age in Total and disease free population (Fig 1,2, 3). Table 6 shows the median, 2.5 and 97.5 percentiles for TSH for the different age groups all increasing with age. The lower limits of the 95% probability interval of the 3 populations were not significantly different. However the upper limit of the total population was considerably higher than the upper limit of the reference population. Regardless of age the 2.5 and 97.5 percentiles of the reference population was 1.1 -5.2 μIU/ml. The number of women with serum TSH (> 4.5 μIU/ml) was highest between the ages 60 -80 years in all the 3 groups (Fig.4 ) and the number of women with low serum TSH ≤ 0.4 μIU/ml was highest in the age group 70 -80 years ( Fig. 5) Only one woman in the "Reference Group" had biochemical hypothyroidism. She was 60 years, her TSH was > 10 μIU/ml and her FT 4 was 0.9 ng/dL. 21 women (5.8%) had their TSH levels between 4.5 and 10 μIU/ml. Two of these women had FT 4 levels less than 0.6 and four had FT 4 levels less than 0.9 ng/dL (Table 7) . Three women (0.83 %) in the reference group had biochemical evidence of hyperthyroidism with TSH less than 0.1 μIU/ml. Two of these three women had FT 4 levels greater than 1.5 ng/dL. Nine women (2.5 %) had mildly suppressed TSH i.e. between 0.1 -0.4 and six of nine (67 %) had FT 4 > 1.5 ng/dL (Table 8) .
DISCUSSION
Pondicherry is a Coastal Union Territory. It is wrongly believed that populations residing in coastal areas do not suffer from iodine deficiency disorders as they consume sea food which are incorrectly believed to be rich in iodine (11) . A pilot study (12, 13, 14) . A later study again on school children (11) revealed that 60% of the population was consuming salt with > 5 ppm of iodine. However no previous studies have been done on the iodine status of women in this region.
This Survey included 505 women who attended the Well Women Health Profile Clinic of the Pondicherry Institute of Medical Sciences. Their ages ranged from 20-80 years. 15.8% had thyroid dysfunction. 11.5 % were hypothyroid (overt 2%, subclinical 9.5%). A recent report from Colorado stated a prevalence of elevated TSH (> 5.1 μIU/ml) in 9.5 % of adult population (15) . Interestingly in our study the prevalence would be 9.3 % if the cut off is raised from 4.5 μIU/ml to 5.1 μIU/ml. The classic study of Sawin et al (16) reported a prevalence of 13 % in females over 60 years of age. In our study (19 %) women over 60 years had elevated TSH levels above 4.5 μIU/ml. In the Rotterdam study on elderly women over 55 years subclinical hypothyroidism was seen in 10.8 % of their participants (7). In our study 9.5 % of women from the total population had subclinical hypothyroidism. In the age group above 55 years 12.5 % of women had subclinical hypothyroidism. The prevalence of overt and subclinical hypothyroidism was much higher than that reported by Hoogendoorn et al (9) and Hollowell et al (10) . It may be mentioned here that Hak et al in their Rotterdam study found 1.1 % of their women to have overt hypothyroidism (7) as compared to 2% in the present study.
Hyperthyroidism was seen in 1.8% (overt 1.2% and Subclinical 0.6%) of the total subjects when the cut off value for TSH was < 0.1 μIU/ml. This is very similar to the Colorado study (15) where 2.2% of their subjects had TSH < 0.3 μIU/ml. Our study is also comparable to the Whickham survey where thyrotoxicosis was seen in 1.6% of the total subject (17) . In more recent surveys Hoogendoorn et al have reported thyrotoxicosis in 1.2 % subjects (overt 0.4 % subclinical 0.8 %) (9) and Hollowell et al in their (NHANES III) study an incidence of 1.3 % (overt 0.5 % and subclinical 0.7 %)(10). It may be noted here that overt thyrotoxicosis was more prominent in our subjects.
60 women (11.9%) had previous history of thyroid disease, goiter or taking thyroid medication. However only 32 (53.3%) had normal thyroid function. This is comparable to the Colorado study (15) and the NHANES III study (10) wherein only 60% and 67 % respectively of their subjects taking thyroid medication were found to have normal TSH i.e appropriately treated. In our study previously diagnosed hyperthyroidism was seen in 10% subjects (8.3% clinical and 1.7 % subclinical) and previously diagnosed hypothyroidism in 36.7 % subjects ie. 33.3 % subclinical and 3.3 % clinical. This is much higher than that reported by Bjoro et al in their Hunt study (18) .
The geometric mean serum TSH for the total population was 2.66 μIU/ml. This value is higher than that observed by Hollowell et al in their NHANES III study 1.47 μIU/ml (10) and Hoogendoorn et al 1.29 μIU/ml (9). In the NHANES III study TSH values were higher in the disease free population (1.50 μIU/ml) but was lower in the reference population (1.40 μIU/ ml). Hoogendoorn et al (9) did not see any difference in the mean TSH in the total and reference population. In our study there was a significant reduction in the mean TSH level in reference group as compared to the total group (p=0.025). An increase in TSH with age was observed in all 3 groups-total, disease free and reference. Several other workers have reported increase in TSH with age (4, 7, 15, 16, 18) . However one study Hoogendoorn et al (9) observed a decrease in TSH level with age. In our study the FT 4 levels did not change markedly with age in all three groups. There was a slight decline in FT 3 levels with age. This was more marked in the total and disease free population where an increase in the TSH at age 60 -79 was marked by a decline in FT 3 . In the reference population there was however a slight increase in FT 3 upto 70 years after which it declined. Kundsen et al have also reported an increase in FT 3 with age (19) . The mean FT 4 levels in the total population was 1.31 ng/dl (16.89 pg mol/L) and FT 3 was 3.01 pg/ml. There was no significant difference in mean FT 3 and FT 4 levels between groups. Hoogendoorn et al reported an FT 4 concentration of 13.56 pmol/L. They observed no difference in mean FT 4 between the 3 groups. Contrary to our observation they reported an increase in FT 4 with age (9).
It has been proposed that reference intervals for thyroid function tests should be based on the 95% probability intervals obtained in a well selected group of healthy people (20) . NHANES III, a survey designed to give national normative
Thyroid Disorders in Women of Puducherry
estimates of the health and nutritional status of the US population found in the total female population a median serum TSH of 1.49 μIU/ml with 2.5 and 97.5 percentile of 0.21 and 7.12 μIU/ml respectively (10). However in the reference population median TSH was 1.39 μIU/ml and 2.5 and 97.5 th percentile were 0.41 and 4.09 μIU/ml. In our study the median serum TSH was 2.0 μIU/ml in the total population and 1.49 μIU/ml in the reference population, which was comparable to the NHANES study. The 2.5 and 97.5 percentile in the total was 1.1 and 8.8 μIU/ml respectively and in the reference 1.1 and 5.2 μIU/ml. The difference in TSH value between these 2 population particularly the 97.5 percentiles has initiated a discussion on whether the TSH reference interval should be based on the total population or on such a reference population (20) .
In our study as in the NHANES III (9) the lower limit in the two groups (total and reference) were the same but the upper limit was considerably lower in the reference population than in the total population. Our median of 1.9 and upper limit of 5.20 μIU/ml corroborated well with the 'HUNT' study (18) who reported a median of 1.60 and an upper limit of 5.70 in females. The normal range given on a laboratory report is actually only a reference range for an ostensibly normal population usually derived from cross-sectional studies of population uncorrected for any underlying or occult disease. For TSH it has earlier ranged from 0.5-7.0 mU/L. With refinement of techniques it has dropped to 0.5-5.5 mU/L(21). Other confounding factors include individual and ethnic variations. The issue of a true normal range of TSH therefore relates to the issues of screening and early treatment.
The number of women with serum TSH > 4.5 μIU/ml was highest between 60-80 years in all 3 groups (fig.4) . The overall prevalence has been reported to be 4 -10 % in the general population and upto 20% in women older than 60 years (16, 19) . Our overall prevalence in this age group was 22%. The number of women with low serum TSH ≤ 0.4μIU/ml was highest in the age group 70 -80 years and the percentage was 13.15 %.
Only one women in the reference population (0.27 %) had overt hypothyroidism with TSH > 10 μIU/ml and FT4 ≤ 0.9 ng/ dL. In the Hunt study (18) 0.9% of women had TSH ≥ 10 μIU/ ml and 5.1 % had TSH between 4 and 10 μIU/ml as compared to 5.8 % in our study. In our study 0.83% of women had TSH< 0.1 μIU/ml and 2.5% had a TSH between 0.1 -0.4 μIU/ml. In the Hunt study 0.46 % of women had TSH < 0.05 μIU/ml and 0.33% and TSH between 0.2 and 0.5 μIU/ml (18).
Both overt hyper and hypothyroidism have a variety of adverse effects and should be treated. However diagnosis and treatment of subclinical thyroid function remains controversial. It has been reported that subclinical hyperthyroidism is a risk factor for atrial fibrillation particularly in older persons (18) . However, a recent report from Netherland demonstrates that subclinical hypothyroidism is also a strong indicator of risk for atherosclerosis and myocardial infarction in elderly females (21) .
This is the first study conducted on women from this coastal region of Puducherry, South India, with respect to thyroid disorders. This study demonstrates that Hypothyroidism mainly subclinical hypothyroidism was alarmingly high in this region.
The percentage of women with elevated TSH was particularly high in the 60-80 years age group. This indicates that thyroid disease should be considered during routine evaluation of this susceptible group and should be followed by appropriate detection and treatment. The finding that a large number of women unknowingly have laboratory evidence of thyroid dysfunction supports the usefulness of screening for early detection. In the elderly and women of perimenopausal age where TSH levels were elevated, further research may determine whether treatment of subclinical hypothyroidism will benefit in preventing adverse health outcomes such as Osteoporosis, Cardiovascular diseases and Hyperlipidemia. We hope to extend the study to a larger cross section of men and women in this region keeping in mind environmental and etiological factors like auto immunity, drugs, Iodine and nonthyroidal illness.
